5 Result(s)
within
Article
Chun-Ru Chien
Health Administration
Health Economics
-
Article
Rising Economic Burden of Renal Cell Carcinoma among Elderly Patients in the USA: Part II—An Updated Analysis of SEER-Medicare Data
The influx of new oncologic technologies has changed the treatment landscape of renal cell carcincoma (RCC) in the last decade. This study updated a previously published paper on the economic burden of RCC in ...
-
Article
Economic Burden of Renal Cell Carcinoma—Part I: An Updated Review
The economic burden of renal cell carcinoma (RCC) had been reported to be significant in a previous review published in 2011.
-
Article
Cost-Effectiveness Analyses of Targeted Oral Anti-Cancer Drugs: A Systematic Review
Over the last 15 years, a paradigm shift in oncology has led to the approval of dozens of targeted oral anti-cancer medications (OAMs), which have become the standard of care for certain cancers. While more co...
-
Article
Economic Burden of Renal Cell Carcinoma
The economic burden of renal cell carcinoma (RCC) came into sharp focus when the UK National Institute for Health and Clinical Excellence (NICE) denied coverage (later reversed) of sunitinib for metastatic RCC...
-
Article
Economic Burden of Renal Cell Carcinoma in the US
Introduction: The economic burden of renal cell carcinoma (RCC) came into sharp focus when the UK’s National Institute for Health and Clinical Excellence denied coverage (later reversed) of sunit...
